Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

NCT00647244 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162 ·Status: COMPLETED ·Phase: PHASE2

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

NCT00044577 ·Status: COMPLETED ·Phase: PHASE3

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

NCT00440947 ·Status: COMPLETED ·Phase: PHASE3

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

NCT00063804 ·Status: COMPLETED ·Phase: PHASE1

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

NCT00885664 ·Status: COMPLETED ·Phase: PHASE4

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

NCT00615810 ·Status: COMPLETED ·Phase: PHASE4

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

NCT00102986 ·Status: COMPLETED ·Phase: NA

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

NCT01073761 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

NCT00357552 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

NCT00002201 ·Status: COMPLETED ·Phase: NA

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

NCT00411957 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

NCT00772902 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women

NCT02652624 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

NCT02547870 ·Status: COMPLETED ·Phase: PHASE1

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

NCT00435929 ·Status: COMPLETED ·Phase: PHASE1

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

NCT00931463 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir/Ritonavir Maintenance Therapy

NCT00084019 ·Status: COMPLETED ·Phase: NA

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

NCT00004578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00002364 ·Status: COMPLETED ·Phase: PHASE2